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Abstract
The junctional adhesion molecule (JAM)-C is a widely expressed adhesion molecule regulating cell adhesion, cell polarity
and inflammation. JAM-C expression and function in the central nervous system (CNS) has been poorly characterized to
date. Here we show that JAM-C2/2 mice backcrossed onto the C57BL/6 genetic background developed a severe
hydrocephalus. An in depth immunohistochemical study revealed specific immunostaining for JAM-C in vascular
endothelial cells in the CNS parenchyma, the meninges and in the choroid plexus of healthy C57BL/6 mice. Additional JAM-
C immunostaining was detected on ependymal cells lining the ventricles and on choroid plexus epithelial cells. Despite the
presence of hemorrhages in the brains of JAM-C2/2 mice, our study demonstrates that development of the hydrocephalus
was not due to a vascular function of JAM-C as endothelial re-expression of JAM-C failed to rescue the hydrocephalus
phenotype of JAM-C2/2 C57BL/6 mice. Evaluation of cerebrospinal fluid (CSF) circulation within the ventricular system of
JAM-C2/2 mice excluded occlusion of the cerebral aqueduct as the cause of hydrocephalus development but showed the
acquisition of a block or reduction of CSF drainage from the lateral to the 3rd ventricle in JAM-C2/2 C57BL/6 mice. Taken
together, our study suggests that JAM-C2/2 C57BL/6 mice model the important role for JAM-C in brain development and
CSF homeostasis as recently observed in humans with a loss-of-function mutation in JAM-C.
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Introduction
Junctional adhesion molecules C (JAM-C) (previously referred
to as hJAM-3 and mJAM-2) is a type I transmembrane protein
and a member of the immunoglobulin (Ig) superfamily. Based on
its molecular structure JAM-C has been assigned together with
JAM-A, JAM-B, JAM-4, JAM-L, ESAM and CAR to the CTX
sub-family of the Ig superfamily. The extracellular domain of
JAM-C consists of a membrane distal VH -and a membrane
proximal C2-type Ig-like domain, a single transmembrane segment
and a relatively short cytoplasmic tail with four putative
phosphorylation sites and a PDZ-domain binding motif that
allows interaction of JAM-C with different scaffolding proteins [1].
JAM-C was orignially described on vascular and lymphatic
endothelial cells, where it localizes to cell-cell contacts [2] and on
human T cells [3]. Since then expression of human JAM-C has
been detected on additional subsets of leukocytes as well as
lymphomas and on platelets (summarized in [1]. In contrast,
expression of JAM-C in mice was found to be restricted to
hematopoietic precursors and is absent on differentiated leuko-
cytes [4,5]. Furthermore, expression of JAM-C has been described
on a wide range of non-hematopoietic cells including endothelial
and epithelial cells [6], fibroblasts [7], smooth muscle cells [8] and
spermatids [9].
In endothelial and epithelial cells JAM-C localizes to intercel-
lular contacts. With its extracellular domain JAM-C can engage in
homophilic binding, adhere to JAM-B and the integrins aMb2
and aX b2summarized in [1]) and has therefore been assigned an
important role in mediating leukocyte migration across endothelial
and epithelial barriers in a number of inflammatory settings [4,10]
and during ischemia/reperfusion [11]. Through its cytoplasmic
tail JAM-C binds to ZO-1 and PAR-3 suggesting a predominant
localization of JAM-C in endothelial and epithelial tight junctions
and a possible role in cell polarization [12]. An essential role of
JAM-C in cell polarization has in fact been proven by the
observation that JAM-C2/2 mice that fail to differentiate round
spermatids into polarized mature spermatozoa and thus show
male infertility [9]. Finally, JAM-C has also been shown to be
involved in tumor growth and metastasis [13][14].
Due to this broad spectrum of biological functions, it is not
surprising that JAM-C2/2 mice were found to exhibit additional
severe phenotypes including growth retardation, megaoesophagus,
disturbed neutrophil homeostasis and increased susceptibility to
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opportunistic infections, resulting in poor survival under conven-
tional housing conditions [15]. Housing of JAM-C2/2 mice in
ventilated isolaters was found to partially rescue this phenotype
confirming an important role of JAM-C in fighting opportunistic
infections. Finally, re-introduction of vascular JAM-C expression
rescued granulocyte homeostasis and survival of JAM-C2/2 mice,
emphasizing the importance of endothelial JAM-C in proper
immune function [15,16].
Recent studies have provided evidence for a role of JAM-C in
the organization of the peripheral nervous system, where it was
found to be expressed in Schwann cells of myelinated peripheral
nerves and in perineural cells [17][18]. In contrast JAM-C
expression was described to be absent in the central nervous
system (CNS) in some studies [2,17] but not others [3]. The recent
discovery of a homozygous mutation in JAM-C in a large
consanguineous family from the United Arab Emirates, members
of which developed a rare autosomal-recessive syndrome charac-
terized by severe hemorrhagic destruction of the brain, suggest a
novel, previously unrecognized role for JAM-C in maintaining
cerebrovascular integrity [19].
To further study the role of JAM-C in the development and
maintenance of the blood-brain barrier (BBB) and in neurological
disorders in vivo, we have backcrossed JAM-C2/2 mice into the
C57BL/6 background. We found that JAM-C2/2 C57BL/6 mice
developed a severe hydrocephalus, characterized by extremely
enlarged lateral ventricles, cortical thinning and disturbances in
CSF circulation. JAM-C expression could be localized to the BBB
and choroid plexus endothelial cells and to choroid plexus
epithelial cells. Notably, JAM-C was highly expressed in ependy-
mal cells lining the ventricles. Although we found numerous
hemorrhages in JAM-C2/2 C57BL/6 mice the development of
the hydrocephalus was independent of JAM-C expression by
endothelial cells, as endothelial cell specific re-expression of JAM-
C in JAM-C2/2 mice neither rescued the survival nor affected the
incidence or severity of the hydrocephalus. Our study therefore
suggests an important role for JAM-C in brain development and
CSF homeostasis and shows that JAM-C2/2 C57BL/6 mice
provide a valuable model for the defects recently observed in
humans with a loss-of-function mutation in JAM-C [19].
Materials and Methods
Mice
Mice were bred in individually ventilated cages (IVC) at SPF
conditions according to the animal protection law of the Kanton
Bern, Switzerland. Breeding of mice and all animal experiments
shown in this study have been approved by the vetenary office of
the Kanton Bern under the permission number 48/08. JAM-C
deficient mice produced by insertion of an IRES-LacZ-pA cassette
and neomycin resistance cassette and transgenic mice with
endothelial-specific overepression of JAM-C (pHHNS-JAM-C)
referred to as Tie2 JAM-C mice, were described previously [4,9].
Both lines were backcrossed onto the C57BL/6 background for 8
to 12 generations in our laboratory. Production of JAM-C2/2//
Tie2 JAM-C C57BL/6 mice was achieved by crossing JAM-C+/2
C57BL/6 mice with Tie2 JAM-C C57BL/6 mice resulting in
JAM-C+/2//Tie2 JAM-C C57BL/6 mice and subsequent cross-
ing with JAM-C+/2 C57BL/6 mice.
Scoring of the Severity of Hydrocephalus Development
Hydrocephalus development was scored as follows: 0 =macro-
scopically normal phenotype; 1 = normal snout, slightly enlarged
skull; 2 = pointed snout, enlarged skull, often untended coat;
3 = extremely pointed snout, extremely enlarged skull, untended
coat.
Genotyping of JAM-C2/2 Mice and JAM-C2/2 Mice
Transgenic for Tie2 JAM-C
Tail biopsies were digested with proteinase K (Merck) to extract
genomic DNA. Samples were subsequently subjected to polymer-
ase chain reaction. To identify mice that carry the JAM-C neo
allele the following primer pair was used: 59 -TCATGTGGA-
TAGCCACAACA- 39 and 59 -ACATCTGTGCGACCTGCCA-
39 (product sizes were 350 bps from the wildtype and 450 bp from
the JAM-C neo allele, respectively). Amplification with the primers
59 -GGGAAGTCGCAAAGTTGTGAGTT- 39 and 59 -
GCTCTAGACAGTGTTGCCGTCT- 39 resulted in a product
of 520 bps, in case mice were transgenic for the Tie2 JAM-C
construct.
Antibodies
For immunofluorescence stainings the following primary
antibodies were used: 10 mg/ml polyclonal goat anti-mouse
JAM-C (R&D systems, USA), polyclonal rabbit anti-JAM-C 526
(diluted 1/1000) and 1 mg/ml affinity-purified 526 [13], 10 mg/
ml rat monoclonal anti-JAM-C (clone H33, from B. Imhof,
Geneva, Switzerland [2]), undiluted monoclonal rat anti-mouse
PECAM-1 hybridoma supernatants (clone Mec13.3 obtained
from ATCC, USA; clone GC5.1 from B. Imhof [20]), 0.25 mg/
ml polyclonal rabbit anti-human fibronectin that cross-reacts
with mouse fibronectin and anti glial fibrillary acidic protein
(GFAP) (DAKO Z0334, Denmark), and as isotype controls
10 mg/ml normal goat IgG, 10 mg/ml normal rabbit IgG (both
R&D systems) and 5 mg/ml rat IgG2b (BD Bioscience,
Switzerland). Additional antibodies used according to the
recommendation of the manufacturer were: anti-neurofilament
(NF; Sigma-Aldrich, USA), neuron-specific class III beta-tubulin
(Tuj1; Covance, USA), rat anti-myelin basic protein (Millipore
MAB386). Secondary antibodies were 3 mg/ml Cy3-conjugated
donkey anti-goat IgG, 3 mg/ml Cy3-conjugated goat anti-rabbit
IgG, 3 mg/ml Cy3-conjugated goat anti-rat IgG and 10 mg/ml
AlexaFluor488-conjugated goat anti-rat IgG (all from Jackson
ImmunoResearch Laboratories, Switzerland). For detection of
endogenous mouse IgG by immunohistochemistry, 10 mg/ml
biotinylated goat-anti mouse IgG was used.
Immunofluorescence Analysis
Preparation of mouse tissue and staining procedures were
performed mainly like published previously [21]. Briefly, mice
were perfused with PBS or 1% formaldehyde in PBS through
the left ventricle of the heart. Dissected tissues were embedded
in Tissue-Tek (Sakura, Netherlands), frozen and stored at
280uC. For immunofluorescence stainings 6 mm cryostat
sections were fixed in ethanol for 10 min at 4uC, followed by
acetone for 1 min at room temperature with the exception to
immunostaining for MBP, which required a fixation of 4%
PFA/PBS for 10 min at room temperature. Blocking solution
was composed of 10% normal rabbit serum in Tris-buffered
saline (TBS). Primary antibodies were diluted in blocking
solution and secondary antibodies in TBS with 10% normal
mouse serum. Antibody incubation was performed for 1 h at
room temperature. Sections were washed with TBS between
incubation steps and finally mounted with Mowiol (Sigma-
Aldrich, USA).
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Immunohistochemistry and Histology
For immunohistochemistry 6 mm cryostat sections were fixed in
aceton for 10 min at 220uC, followed by blocking with 100%
normal rabbit serum (AbD Serotec, Germany). Subsequently
biotinylated primary antibody (diluted in PBS/0.5% BSA) and
horseradish peroxidase-conjugated Streptavidin (Vector Labora-
tories, USA) were incubated with the sections for 30 min each. In
between, sections were washed with PBS and PBS/0.1%
Tween20. Sections were then developed with AEC substrate from
Vectastain ABC Kit for 10 min (Vector Laboratories, USA),
counterstained with hemalum (Merck, Germany) and coverslipped
with Aquatex (Merck, Germany).
For GFAP and NF/Tuj1 staining, 3 mm paraffin sections were
dewaxed and antigen retrieval was carried out in citrate buffer
(pH 6.0). Blocking was either performed with normal goat serum
(NGS) for GFAP or with the mouse-on-mouse (MOM, Vector
Laboratories, USA) kit for NF/Tuj1, according to the manufac-
turers’ protocol. Subsequently, appropriate horseradish peroxi-
dase-conjugated secondary antibodies were incubated with the
sections for 1 h, followed by washes with PBS. Sections were then
developed with AEC substrate from Vectastain ABC Kit for
20 min (Vector Laboratories, USA), counterstained with hemalum
(Merck, Germany) and coverslipped with Aquatex (Merck,
Germany).
Neuropathological examination of the murine brains was
performed in serial sections by classical HE stains as well as iron
staining for the detection of elder hemorrhages.
Ventricular DiI Injections
For intracranial DiI injection into the lateral ventricle, 8 to 10
weeks old mice were anesthetized by intraperitoneal injection of
Ketamin/Xylazin according to approved experimental protocols
(University of Frankfurt, Germany). Mice were inserted into a
stereotactic device and injected into the left lateral ventricle at
0,0 mm anterior-posterior to bregma, 0.75 mm left to midline and
1,5 mm ventral from the dura, via a pre-drilled hole in the skull.
The hole was sealed with dental wax and the skin was sewed. After
24 h of incubation mice were anesthetized by a sub-lethal
intraperitoneal injection of Ketamin/Xylazin, followed by cardiac
perfusion for 2 minutes with PBS and subsequently for 4 minutes
with 4% PFA. Mouse brains were removed and incubated over
night in 4% PFA at 4uC. The next day they were transferred in
0.1 M phosphate buffer pH 7.4 containing 30% sucrose and
incubated for several days at 4uC until brains were totally
infiltrated with the solution. Brains were embedded in OCT
compound for 12 mm cryo-sections.
Ethics Statement
This is not applicable to the present study.
Results
JAM-C2/2 C57BL/6 Mice Develop a Severe
Hydrocephalus
When backcrossing JAM-C2/2 mice into the C57BL/6
background we found that JAM-C2/2 C57BL/6 mice developed
a severe hydrocephalus. JAM-C2/2 mice, but not JAM-C+/2 or
wildtype littermates presented with growth retardation accompa-
nied by an extremely enlarged and deformed skull (Figure 1A).
Immunohistological analysis of frozen sections of brain tissues
revealed dramatically dilated lateral ventricles, a markedly thinned
cortex and, due to the increased hydrostatic pressure, a dislocation
of the hippocampus in JAM-C2/2 mice (Figure 1B and not
shown).
Although JAM-C2/2 mice housed in individually ventilated
cages were born at correct Mendelian ratios (25.4% JAM-C2/2;
47.8% JAM-C+/2 and 26.9% wildtype offspring of 67 animals
genotyped between P4 and P11) only 50% of the JAM-C2/2 mice
survived until weaning at postnatal day 21 and two thirds of those
developed a hydrocephalus within the first 4 to 8 weeks after birth
(Table 1). No significant gender-specific differences in survival of
JAM-C2/2 mice or incidence of hydrocephalus formation were
detectable (Table 1).
To investigate the development of the hydrocephalus over time
in more detail, we developed a visual scoring scale evaluating the
severity of the hydrocephalus as follows: 0 =macroscopically
normal phenotype; 1 = normal snout, slightly enlarged skull;
2 = pointed snout, enlarged skull, often untended coat; 3 = ex-
tremely pointed snout, extremely enlarged skull (Figure 2A). The
increase in hydrocephalus severity of seven JAM-C2/2 males was
in depth monitored on a daily basis over a period of two months,
starting at weaning with mice that had not yet developed a
macroscopic hydrocephalus (Figure 2B). A slightly enlarged skull
(score 1) was first detected between 4 to 8 weeks of age. On
average, 16 days after scoring 1, mice developed a score 2 and
eight days later a score 3. Additionally, we observed that a severe
hydrocephalus (score 3) was accompanied by an aggravation of the
general health conditions of these animals. Mice displayed a
spastic gait, lethargy, tremor and untended coat and died within
several days. Therefore, all further mice were sacrificed as soon as
they reached score 3.
Taken together, when backcrossed into the C57BL/6 back-
ground, JAM-C2/2 mice developed a hydrocephalus within the
first weeks of life. Severity of this phenotype increased over time
and eventually led to the early death of these animals.
JAM-C is Expressed in the CNS of C57BL/6 Mice
As hydrocephalus development in JAM-C2/2 mice C57BL/6
mice strongly suggested the expression of JAM-C in the CNS, we
performed double-immunofluorescence stainings for JAM-C and
PECAM-1 on brain cryosections from wildtype and JAM-C2/2
C57BL/6 mice. In addition, we analyzed transgenic 57BL/6 mice
overexpressing JAM-C in endothelial cells (Tie2 JAM-C mice).
Comparing different tissue fixation protocols and anti-JAM-C
antibodies available to us (see Material and Methods), we found
reproducible and specific staining for JAM-C in the brain using a
commercially available polyclonal goat anti mouse JAM-C
antibody (R&D). JAM-C immunostaining was observed on
PECAM-1+ endothelial cells of parenchymal and meningeal brain
vessels, but also on endothelial cells of fenestrated microvessels
within the choroid plexus (Figure 3A). Additional JAM-C
immunostaining was detected on the choroid plexus epithelium
of the 4th ventricle and on ependymal cells lining the ventricles
(Figure 3A). As expected, intense JAM-C staining was observed in
the brain vasculature of Tie2 JAM-C mice, with primary
localization to endothelial cell contacts (Figure 3B). No specific
signals were detectable with an isotype control antibody (not
shown) or when JAM-C2/2 brain sections were stained with anti-
mouse JAM-C antibodies (Figure 3C).
Furthermore, we did not detect JAM-C immunostaining on glial
fibrillary acidic protein (GFAP)+ astrocytes (Figure 4). Using the
fixation protocol required to identify myelin-basic protein (MBP)+
oligodendrocytes we failed to see any JAM-C immunostaining on
oligodendrocytes (Figure 4). As this fixation protocol is suboptimal
for the detection of JAM-C we cannot exclude expression of JAM-
C on oligodendrocytes, which has been described before [22,23].
Hydrocephalus in JAM-C2/2 C57BL/6 Mice
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Taken together, expression of JAM-C was detectable on a
variety of cells in the CNS and was not limited to CNS
endothelium.
Hydrocephalus in JAM-C2/2 C57BL/6 Mice is
Accompanied with Reactive Gliosis and Defects in Cortex
Lamination
To evaluate in more detail the pathological alterations
accompanied by the development of the hydrocephalus in JAM-
C2/2 C57BL/6 mice we performed immunohistochemical
stainings for glial fibrillary acidic protein (GFAP), comparing
brains from JAM-C2/2 C57BL/6 mice with a hydrocephalus
score of 1 and 2 with wild-type brains. A large number of reactive
astrocytes with strong GFAP staining was observed in the anterior
and posterior areas of the cortex as well as in the hippocampus of
JAM-C2/2 C57BL/6 mice (Figure 4 and 5A–H). In contrast, the
atrophic cerebellum of JAM-C2/2 C57BL/6 mice did not show
any significant increase in GFAP+ astrocytes when compared to
wild-type control cerebellum (Figure 5I–L).
By staining for the pan-neuronal markers neurofilament (NF)
and the neuron-specific class III beta-tubulin (Tuj1) we observed a
severe disorganization of cortical layers in brains of JAM-C2/2
C57BL/6 mice, including a lack of differentiated pyramidal cells
(Figure 6A–D). In particular, no axonal and dendritic processes
(Figure 6A–D) or MBP+ fibers (Figure 4) could be seen in brains of
JAM-C2/2 C57BL/6 mice that ran perpendicular to the surface
of the brain. The hippocampus as well as the cerebellum did not
show any altered neuronal staining pattern (Figure 6E–H).
Figure 1. JAM-C2/2 C57BL/6 mice develop a severe hydrocephalus. A In comparison to age-matched C57BL/6 wildtype littermates JAM-C2/2
C57BL/6 mice are often smaller and display a hydrocephalus. B Histological analysis of hemalaun-stained brain cryosections reveals greatly enlarged
lateral ventricles (arrows), a strikingly thinned cortex and overall alteration of brain anatomy in JAM-C2/2 C57BL/6 mice.
doi:10.1371/journal.pone.0045619.g001
Table 1. Number of JAM-C2/2 C57BL/6 offspring and hydrocephalus incidence.
Offspring at postnatal day 21* Hydrocephalus (HC)
total number
% JAM-C2/2 offspring (%
expected) JAM-C2/2 pups with HC (%)
JAM-C+/2 or WT pups with HC
(%)
147 12.2 (25.0) 66.7 0
f 77 6.1 77.0 0
m 70 6.1 55.6 0
JAM-C+/2 mice were interbread and offspring was genotyped at postnatal day 21. Abbreviations: f = female offspring; m=male offspring.
doi:10.1371/journal.pone.0045619.t001
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Hydrocephalus in JAM-C2/2 C57BL/6 Mice is
Accompanied by Hemorrhages
As a loss of function mutation of JAM-C in humans was found
to lead to severe hemorrhagic destruction of the brain [19], we
next asked if the development of the hydrocephalus in JAM-C2/2
C57BL/6 mice was due to impaired cerebrovascular integrity and
subsequent bleedings into the brain. Brain tissue sections of JAM-
C2/2 C57BL/6 mice with a hydrocephalus score of 0, 1 and 2
and healthy wild-type C57BL/6 mice were stained with hema-
toxylin and eosin to detect tissue localization of erythrocytes.
Additionally, we performed iron stainings to detect elder
hemorrhages. This revealed fresh, subacute and old intraventric-
ular, subependymal intraparenchymal as well as subarachnoid
hemorrhages determined by the presence of vital erythrocytes,
erythrophages, hemosiderophages and haematoidin pigment,
respectively, in the brains of JAM-C2/2 C57BL/6 mice with a
hydrocephalus but not in brains of JAM-C2/2 C57BL/6 mice
without a hydrocephalus or in wild-type control mice (Figure 6). In
addition, multiple perivascular bleedings were observed in the
brain parenchyma solely in JAM-C2/2 C57BL/6 mice with a
hydrocephalus but were absent in the brains of JAM-C2/2
C57BL/6 mice without a hydrocephalus and in wild-type C57BL/
6 mice (Figure 7). These observations suggest that absence of JAM-
C in the brain might lead to vascular disruption and subsequent
bleedings, which could be causative for the development of the
hydrocephalus. However, this would not rule out secondary
bleedings related to increased intracranial pressure in mice with
hydrocephalus or development of a hydrocephalus as a conse-
quence of malresorption of CSF due to subarachnoid hemorrhage.
Hydrocephalus in JAM-C2/2 C57BL/6 Mice is not Caused
by the Lack of Vascular JAM-C
In order to determine if the lack of endothelial JAM-C
expression in the brain of C57BL/6 mice caused the development
of the hydrocephalus, we bred JAM-C+/2//Tie2-JAM-C mice
with JAM-C+/2 mice and compared the occurrence of the
hydrocephalus and the survival of JAM-C2/2 versus JAM-C2/2
//Tie2 JAM-C offspring. If all genotypes were produced at
Mendelian ratios, i.e. if survival was unaffected by genotype,
12.5% JAM-C2/2 and 12.5% JAM-C2/2//Tie2 JAM-C off-
spring would be expected from these breedings. However, as
shown in Table 2, the percentage of offspring that survived until
weaning was reduced similarly for both of these genotypes (7.1%
JAM-C2/2 and 8.2% JAM-C2/2//Tie2 JAM-C mice). Further-
more, the hydrocephalus incidence of about 65% was not
significantly reduced in JAM-C2/2//Tie2 JAM-C as compared
Figure 2. Hydrocephalus in JAM-C2/2 C57BL/6 mice develops over time. A: Different stages in hydrocephalus severity of JAM-C2/2 C57BL/6
mice are shown with their assigned scores. B: Seven male JAM-C2/2 C57BL/6 mice were scored weekly for changes in hydrocephalus severity. On
average, first hydrocephalus symptoms appeared around 1 month after birth. Score 2 was reached about 2 weeks later. Finally, score 3 developed in
most mice within the following week.
doi:10.1371/journal.pone.0045619.g002
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Figure 3. Expression of JAM-C in the mouse brain. Expression of JAM-C (red) in the brain was detected via indirect immunofluorescence
staining of brain cryosections. Counterstaining for PECAM-1 (green) was performed to identify the vasculature. A In C57BL/6 wildtype mice JAM-C
was localized to parenchymal blood vessels, meningeal vessels, the ependyma, the choroid plexus endothelium and the choroid plexus epithelium of
the 4th ventricle. Distinct junctional JAM-C staining was found in the endothelial cells of brain parenchymal vessels of Tie2 JAM-C brain tissues (B),
while none was detectable in the brain of JAM-C2/2 C57BL/6 mice (C). Bars = 20 mm.
doi:10.1371/journal.pone.0045619.g003
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to JAM-C2/2 mice, with no major differences between male and
female mice (Figure 8). Excluding the possibility that brain
endothelial re-expression of JAM-C was incomplete in JAM-C2/2
//Tie2 JAM-C mice vascular expression of JAM-C was indistin-
guishable by immmunostaining in brains of Tie2 JAM-C and
JAM-C2/2//Tie2 JAM-C mice (data not shown).
Thus, endothelial re-expression of JAM-C failed to rescue the
hydrocephalus phenotype of JAM-C2/2 C57BL/6 mice demon-
strating that lack of JAM-C in the cerebrovascular endothelium is
not the major cause of the development of a hydrocephalus in
JAM-C2/2 C57BL/6 mice.
Evaluation of CSF Circulation within the Ventricular
System of JAM-C2/2 Mice
As we noticed an increasing severity of the hydrocephalus in
individual mice over time, we investigated whether the enlarge-
ment of lateral ventricles could proceed and finally lead to
occlusion of the cerebral aqueduct, a situation also observed in
other hydrocephalus mouse models [24,25]. To this end the
fluorescent dye DiI was injected into the left lateral ventricle of
wildtype and JAM-C2/2 mice to track CSF flow through the
ventricular system (Figure 9A). Under healthy conditions, the dye
follows the CSF movement from the lateral ventricles through the
paired foramina of Monro into the 3rd ventricle, followed by
passage of the cerebral aqueduct and finally reaches the 4th
ventricle (for review see [26]). 24 hours after injection, mice were
sacrificed and brains were frozen, sectioned and cell nuclei were
stained with DAPI. Figure 8B shows DiI (red) distribution in the
ventricular system in sagittal sections of a wildtype C57BL/6 and a
JAM-C2/2 C57BL/6 mouse with pronounced hydrocephalus. In
the wildtype mouse, DiI was detectable in the parenchyma around
the left lateral and the 4th ventricle (Figure 8B, left), while in the
JAM-C2/2 C57BL/6 mouse the dye was distributed around the
lateral ventricle, but was not visible in the displaced 3rd and the 4th
Figure 4. Expression of JAM-C in the mouse brain. Expression of JAM-C (red) in the brain was detected via indirect immunofluorescence
staining of brain cryosections. Counterstaining for GFAP (green) and MBP (green) was performed to identify astrocytes and oligodendrocytes,
respectively. JAM-C immunostaining did not co-localize with GFAP+ astrocytes or MBP+ oligodendrocytes in C57BL/6 wildtype mice (WT) and Tie2
JAM-C mice. Lack of detection of JAM-C immunostaining on blood vessels in WT but not Tie2 JAM-C mice is due to the necessity of using a fixation
protocol for identifying MBP+ oligodendrocytes that is suboptimal for detection of JAM-C. Note that in the neocortex of JAM-C2/2 C57BL/6 mice, no
MBP+ processes running perpendicular to the brain surface are visible. Bars = 50 mm.
doi:10.1371/journal.pone.0045619.g004
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Figure 5. Hydrocephalus in JAM-C2/2 C57BL/6 mice is accompanied by reactive gliosis. Immunostaining for glial fibrillary acidic protein
(GFAP) reveals reactive gliosis in JAM-C2/2 C57BL/6 mice. JAM-C2/2 C57BL/6 mice (symptomatic hydrocephalus score 1 shown here) exhibit
extensive gliosis in the cortex (4C and D) and hippocampus (4G and H) as compared to wild-type littermates (4 A, B, E and F). In the cerebellum of
JAM-C2/2 C57BL/6 only a mild increase of GFAP staining could be observed (4 I and J) as compared to wild-type cerebellum (4 K and L). Bars as
indicated.
doi:10.1371/journal.pone.0045619.g005
Figure 6. Hydrocephalus in JAM-C2/2 C57BL/6 mice is accompanied by loss of cortical layering. Immunostaining for neurofilament (NF)
together with Tuj1 reveals loss of cortical layering in JAM-C2/2 C57BL/6 mice (hydrocephalus score 1 shown; 5 C and D) when compared to wild type
littermates (5 A and B). Inserts in B and D show pyramidal cells. Note that in the JAM-C2/2 C57BL/6 mice no axonal and dendritic processes are
visible. In contrast, the overall structure of the hippocampus (5 E and G) and the cerebellum (5 F and H) of JAM-C2/2 C57BL/6 mice did not show any
detectable alterations in NF/Tuj1 positive cells when compared to wild-type littermates. Bars as indicated.
doi:10.1371/journal.pone.0045619.g006
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ventricle. This strongly suggests that obstruction of the aquaduct
cannot be the primary cause of the hydrocephalus (Figure 9B,
right). To investigate possible differences between several gradu-
ations of hydrocephalus severity, brain coronal sections of two DiI-
injected JAM-C2/2 C57BL/6 mice with score 0 and one JAM-
C2/2 C57BL/6 mouse with score 1 were analyzed and compared
to a C57BL/6 wildtype littermate (Fig. 9C–N). Unfortunately,
injections of mice with more severe hydrocephalus (score 2–3)
were not reliable, due to high intracranial pressure that pushed
CSF and DiI out of the injection channel and because animals
died during or shortly after the procedure. However, already in
JAM-C2/2 mice with moderate hydrocephalus, no DiI was
Figure 7. Hydrocephalus in JAM-C2/2 C57BL/6 mice is accompanied by hemorrhages. A: Hematoxylin and eosin staining showing signs of
fresh (asterisk) and elder (arrows) bleedings within the III. ventricle. Elder bleedings consisted of erythrophages, hemosiderophages and also
haematoidin pigment, the latter indicating bleedings older than 8 days (original magnification: 10x). B: Signs of elder bleedings were also observed
within the aqueduct (arrow indicating hemosiderophage; HE stain; original magnification: 40x). C: Fresh and elder hemorrhages were also seen in the
perivascular spaces (arrow) and within the CNS tissue (asterisk) (HE stain; original magnification 10x). D: Iron staining indicating the presence of
abundant intraparenchymal iron-loaden macrophages (original magnification: 40x). E, F: Subarachnoidal hemorrhages presenting with areas of fresh
(E; arrows; HE staining; original magnification: 10x) and elder bleedings (F; iron staining; original magnification: 40x).
doi:10.1371/journal.pone.0045619.g007
Table 2. Endothelial JAM-C fails to rescue survival of JAM-C2/2 C57BL/6 mice.
total number of pups*
% JAM-C2/2 offspring
(% expected)
% JAM-C2/2//Tie-2 JAM-C offspring
(% expected)
574 7.1 (12.5) 8.2 (12.5)
f 297 8.1 (12.5) 8.8 (12.5)
m 277 6.1 (12.5) 7.6 (12.5)
*JAM-C+/2 and JA-C+/2//Tie-2 JAM-C mice were interbred and offspring was genotyped at postnatal day 21. Abbreviations: f = female offspring; m=male offspring.
doi:10.1371/journal.pone.0045619.t002
Hydrocephalus in JAM-C2/2 C57BL/6 Mice
PLOS ONE | www.plosone.org 9 September 2012 | Volume 7 | Issue 9 | e45619
detectable around the 4th ventricle (Figure 9B) or even 3rd ventricle
(Figure 9J). This is in contrast to the C57BL/6 wildtype control
and the two JAM-C2/2 C57BL/6 mice with score 0, in which DiI
was found in and around the injected lateral, the 3rd and the 4th
ventricles (Figures 9C–E, G–I and K–M). In conclusion, those
JAM-C2/2 C57BL/6 mice developing a hydrocephalus had
acquired impaired CSF drainage from the lateral to the 3rd
ventricle probably due to the occlusion of the foramina of Monro
or due to generally reduced CSF drainage caused by subarachnoid
hemorrhage.
Discussion
The present study extends our knowledge on the expression
pattern of JAM-C in the central nervous system (CNS) and
underlines an important role of JAM-C in brain homeostasis that
can be modeled in JAM-C2/2 C57BL/6 mice, which is strikingly
similar to the recently observed pathology in humans with a loss-
of-function mutation in JAM-C [19].
With the aim to obtain JAM-C2/2 mice in a genetic
background that is useful for studying a variety of neurological
disorders we backcrossed JAM-C2/2 mice onto the genetic
background of C57BL/6 mice. As previously reported for JAM-
C2/2 mice with a mixed 129Sv - C57BL/6 background [15],
JAM-C2/2 C57BL/6 mice were born in correct Mendelian ratios,
but then showed growth retardation and reduced survival.
Unexpectedly, more than 60% of JAM-C2/2 C57BL/6 mice
that survived until weaning (but not their heterozygous or wildtype
littermates) developed a hydrocephalus that increased in severity
over time and finally led to the early death of the affected mice.
We therefore examined the expression of JAM-C in the brains
of C57BL/6 mice by performing extensive immunofluorescence
stainings using a panel of anti-JAM-C antibodies and by
comparing brain sections from C57BL/6 mice, JAM-C2/2
C57BL/6 mice as well as from C57BL/6 mice overexpressing
endothelial JAM-C (Tie-2-JAM-C mice). Using this approach we
detected JAM-C specific immunofluorescence staining on endo-
thelial cells of brain parenchymal and meningeal blood vessels as
well as on endothelial cells of the fenestrated choroid plexus
microvessels. Additionally, JAM-C immunostaining was seen on
ependymal cells lining the ventricular system and on the choroid
plexus epithelium of the 4th ventricle. Our findings are in line with
recent obervations detecting JAM-C specific immunostaining in
mouse brain endothelial and ependymal cells [22][23]. In addition
these studies assigned expression of JAM-C to oligodendrocytes
and neural stem cells. In apparent contast to these recent findings
JAM-C has originally been reported to be absent in the mouse
brain [17,27]. We speculate that this might be due to different
antibodies used, as also in our hands not all tested anti-JAM-C
antibodies performed well on the highly myelinated CNS tissue.
Differences in tissue fixation and thus epitope exposure as
experienced by us might additionally lead to lack of JAM-C
immunoreactivity within the CNS described in those earlier
studies.
Hydrocephalus is a consequence of net cerebrospinal fluid (CSF)
accumulation in the CNS and has multiple causes. According to
the classical view there is either impairment of CSF flow within the
ventricular system (non-communicating hydrocephalus) or dis-
turbed absorption of CSF (for review see [26]). In addition
dysplasia of the cerebral cortex and neuronal degeneration due to
several other reasons appear to be implicated in hydrocephalus
pathogenesis [28–30]. In mammals the generally accepted model
of CSF circulation assumes a bulk flow of choroid plexus-produced
CSF from the lateral ventricles to the 3rd and 4th ventricle and
finally into the subarachnoid space, where it is absorbed mainly by
arachnoid villi (reviewed in [26]). Nevertheless, the drainage of
CSF through BBB capillaries is discussed as well (reviewed in [31]).
Depending on the cell type and experimental condition JAM-C
has been shown to either enhance or reduce paracellular
permeability [2,27,32–34]. JAM-C might therefore be implicated
in regulating BBB integrity or the absorption of CSF through the
BBB. Dysfunction of the brain vasculature in JAM-C2/2 C57BL/
6 mice was suggested by the observation of perivascular and
subarachoidal hemorrhages. Therefore we attempted to rescue
endothelial JAM-C expression by introducing the Tie2-JAM-C
transgenic line into the JAM-C2/2 background. Yet, neither
mortality nor hydrocephalus incidence were reduced in the
resulting JAM-C2/2//Tie2 JAM-C mice. This finding indicates
that hydrocephalus development in JAM-C2/2 C57BL/6 mice
depends on non-endothelial JAM-C expression. This is further
underlined by the recent observations that C57BL/6 mice with
endothelial-cell specific deletion of JAM-C neither show a high
mortality rate nor development of a hydrocephalus [35]. Genetic
background also plays a key role, as hydrocephalus development
was not observed in JAM-C2/2 mice in a genetically mixed
background [9,15,17]. The latter might be due to unknown
modifier genes that influence the effects of JAM-C absence, as
reported for other mutant mouse models that also presented a
hydrocephalus solely in the C57BL/6 background [29,36–39].
Occlusion of the cerebral aqueduct is a widely accepted cause of
hydrocephalus, but is also observed secondary to ventricular
dilation [26]. To test if the hydrocephalus in JAM-C2/2 C57BL/6
mice displayed aqueduct occlusion we injected the fluorescent
tracer DiI into the left lateral ventricle of wildtype and JAM-C2/2
C57BL/6 mice and evaluated its distribution within the ventric-
ular system. As expected, in wildtype and non-hydrocephalic
JAM-C2/2 C57BL/6 mice DiI was detectable in and around the
lateral, 3rd and 4th ventricles, while in JAM-C2/2 C57BL/6 mice
with symptomatic hydrocephalus the dye was prevented to reach
the 4th or even the 3rd ventricle. By performing histology on serial
sections of two hydrocephalic JAM-C2/2 and two C57BL/6
wildtype mice we additionally failed to show any malformation of
the cerebral aqueduct (not shown). Thus, occlusion of the
aqueduct is not the cause of the development of a hydrocephalus
in JAM-C2/2 C57BL/6 mice. Rather hydrocephalic JAM-C2/2
C57BL/6 mice have acquired a reduced CSF drainage from the
lateral to the 3rd ventricle suggesting either a CSF drainage block
at the level of the foramina of Monro or generally reduced CSF
Figure 8. Endothelial re-expression of JAM-C does not rescue
the hydrocephalus of JAM-C2/2 C57BL/6 mice. 38 JAM-C2/2
C57BL/6 mice (21 females and 17 males) and 40 JAM-C2/2//Tie-2 JAM-C
C57BL/6 mice (25 females and 15 males) were analyzed for
hydrocephalus development. In comparison to JAM-C2/2 C57BL/6
mice no major difference in the hydrocephalus incidence could be
observed when the expression of endothelial JAM-C was rescued in
JAM-C2/2 C57BL/6 littermates.
doi:10.1371/journal.pone.0045619.g008
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drainage in these mice that may be due to subarachnoid
hemorrhage. Ependymal cells cover the walls of the ventricular
system and their cilia movement seems essential for adequate CSF
flow [40–42]. Moreover, absence or disruption of proper cilia
motility is associated with hydrocephalus in men and rodents [43–
45]. JAM-C expressed in ependymal cells as found by us in the
present study and others before [22,23] might be involved in
regulating ependymal polarization and thus permeability of these
CSF facing epithelial layers [9,12].
An alternative or complementary reason for the development of
a hydrocephalus in JAM-C2/2 C57BL/6 mice might be due to
JAM-C expression in CNS parenchmyal cells. The Src-family
tyrosine kinase Fyn has been reported to be essential for
oligodendrocyte development and Fyn-deficiency was shown to
lead to cortical thinning, axon degeneration and subsequent severe
hydrocephalus [29]. Given the fact that JAM-C was recently found
in human oligodendrocytes and was suggested to act upstream of
c-Src [22], combined with our observation of JAM-C expression in
the cerebral cortex, loss of cortical layering and cortical thinning in
hydrocephalic JAM-C2/2 C57BL/6 mice, JAM-C could be
implicated in the above described pathogenesis.
Additionally, JAM-C has been observed in neural stem cells in
the developing and adult brain and has been suggested to mediate
asymmetric cell division and to maintain the brain stem cell
compartment by inhibiting neural stem cell migration into deeper
cortical layers [23]. JAM-C expressed by cerebellar granule
neurons was shown to be essential for their migration out of
germinal zones during post-natal brain morphogenesis by recruit-
ing JAM-C to the neuronal surface [46]. Combined with the
previous observation that impaired migration of cortical neurons
can induce congenital hydrocephalus [28] these observations allow
to speculate on an alternative etiology of hydrocephalus develop-
ment in JAM-C2/2 C57BL/6 mice.
In contrast to occlusion of CSF flow, the development of a
hydrocephalus may be the result of CSF overproduction linked to
choroid plexus papilloma or diffuse villous hyperplasia of the
choroid plexus (for review see [47,48]). As we never observed any
changes in choroid plexus morphology in hydrocephalic JAM-C2/
Figure 9. Lateral ventricle DiI injections do not reach the 4th ventricle of JAM-C2/2 mice with symptomatic hydrocephalus. A
Injection scheme for DiI is shown. B DiI (red) distribution in the ventricular system in sagittal sections from a C57BL/6 wild-type and a hydrocephalic
JAM-C2/2 C57BL/6 mouse is shown. Nuclear staining (DAPI) is shown in blue, unspecific fluorescence in green. LV = lateral ventricle; asterisk = 3rd
ventricle; arrows point to 4th ventricle. C–F DiI distribution within the lateral ventricles. G–J DiI distribution within the 3rd ventricle. Note that in J
(JAM-C2/2 score 1) the 3rd ventricle contains little or no DiI. K–N DiI distribution within the 4th ventricle. Note that in N (JAM-C2/2 score 1) the 4th
ventricle contains no DiI.
doi:10.1371/journal.pone.0045619.g009
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2 C57BL/6 mice we consider it less likely that the absence of
JAM-C in the 4th ventricle choroid plexus epithelium is implicated
in hydrocephalus initiation by overproduction of CSF.
Taken together, the present study further confirms JAM-C
expression in the brain of mice, more precisely the BBB and
choroid plexus endothelial cells, the epithelial cells of the 4th
ventricle choroid plexus, and the ependymal cells lining the
ventricles. JAM-C2/2 mice in the C57BL/6 genetic background
developed a severe and progressive hydrocephalus, characterized
by extremely enlarged lateral ventricles accompanied by hippo-
campal dislocation, cortical thinning, loss of proper cortical
layering with subsequent reactive gliosis as well as hemorrhages
in different brain compartments and obstruction of CSF circula-
tion. In contrast to JAM-C2/2 mice in mixed 129Sv - C57BL/6
background, JAM-C2/2 C57BL/6 mice therefore mimic part of
the CNS pathology recently observed in members a large
consanguineous family carrying a rare mutation in JAM-C leading
to a non-functional protein [19]. Affected individuals develop a
syndrome characterized by severe hemorrhagic destruction of the
brain, sub-ependymal calcifications, enlarged ventricles and
congenital cataracts partially reflected in JAM-C2/2 C57BL/6
mice. As endothelial re-expression of JAM-C failed to increase
survival or inhibit hydrocephalus formation in JAM-C2/2//Tie2
JAM-C mice our observations point to non-endothelial JAM-C to
be important for CNS homeostasis, although further investigations
are required to elucidate its exact role in hydrocephalus
pathogenesis.
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